SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Rigel Pharmaceuticals, Inc. (RIGL)
RIGL 30.65-2.9%9:30 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: scaram(o)uche who wrote (478)2/22/2010 12:06:33 PM
From: mopgcw  Read Replies (1) of 566
 
a piece of smoke and speculation; i am not familiar with the author so maybe his credibility warrants more respect.

In plain terms, the deal gives RIGL $100mm cash and a lot of money on the back end, while AZ pays the freight to get there. nice in my book. are there other deals out there that are better? sure. Worse? sure.

I too can speculate on the royalty rate, and maybe the market "knows", but this commentary adds no real insight imho.

how was RIGL pumping the stock for a following? tough claim to make without any evidence.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext